491 related articles for article (PubMed ID: 32255127)
41. A single-beam of light priming the immune responses and boosting cancer photoimmunotherapy.
Sun Y; Han R; Wang J; Qin Y; Ren Z; Feng X; Liu Q; Wang X
J Control Release; 2022 Oct; 350():734-747. PubMed ID: 36063959
[TBL] [Abstract][Full Text] [Related]
42. The synthesis of LA-Fe
Chen Y; Zhang F; Wang Q; Lin H; Tong R; An N; Qu F
Dalton Trans; 2018 Feb; 47(7):2435-2443. PubMed ID: 29379913
[TBL] [Abstract][Full Text] [Related]
43. IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation.
Wang Y; Wang H; Song Y; Lv M; Mao Y; Song H; Wang Y; Nie G; Liu X; Cui J; Zou X
J Nanobiotechnology; 2022 Mar; 20(1):96. PubMed ID: 35236356
[TBL] [Abstract][Full Text] [Related]
44. Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments.
Qu H; Li L; Chen H; Tang M; Cheng W; Lin TY; Li L; Li B; Xue X
J Control Release; 2023 Nov; 363():361-375. PubMed ID: 37751826
[TBL] [Abstract][Full Text] [Related]
45. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
[TBL] [Abstract][Full Text] [Related]
46. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
[TBL] [Abstract][Full Text] [Related]
47. Fe(III)-Chelated Polydopamine Nanoparticles for Synergistic Tumor Therapies of Enhanced Photothermal Ablation and Antitumor Immune Activation.
Xu N; Hu A; Pu X; Li J; Wang X; Wang J; Huang Z; Liao X; Yin G
ACS Appl Mater Interfaces; 2022 Apr; 14(14):15894-15910. PubMed ID: 35357136
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation.
Rahimi-Moghaddam F; Azarpira N; Sattarahmady N
Lasers Med Sci; 2018 Nov; 33(8):1769-1779. PubMed ID: 29790012
[TBL] [Abstract][Full Text] [Related]
49. Second near-infrared photothermal-amplified immunotherapy using photoactivatable composite nanostimulators.
Sun H; Yu T; Li X; Lei Y; Li J; Wang X; Peng P; Ni D; Wang X; Luo Y
J Nanobiotechnology; 2021 Dec; 19(1):433. PubMed ID: 34930269
[TBL] [Abstract][Full Text] [Related]
50. Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer.
Sun J; Wan Z; Xu J; Luo Z; Ren P; Zhang B; Diao D; Huang Y; Li S
Biomaterials; 2021 Feb; 269():120629. PubMed ID: 33387938
[TBL] [Abstract][Full Text] [Related]
51. Reprogramming the Tumor Microenvironment through Second-Near-Infrared-Window Photothermal Genome Editing of PD-L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy.
Tang H; Xu X; Chen Y; Xin H; Wan T; Li B; Pan H; Li D; Ping Y
Adv Mater; 2021 Mar; 33(12):e2006003. PubMed ID: 33538047
[TBL] [Abstract][Full Text] [Related]
52. The potentiated checkpoint blockade immunotherapy by ROS-responsive nanocarrier-mediated cascade chemo-photodynamic therapy.
Hu L; Cao Z; Ma L; Liu Z; Liao G; Wang J; Shen S; Li D; Yang X
Biomaterials; 2019 Dec; 223():119469. PubMed ID: 31520886
[TBL] [Abstract][Full Text] [Related]
53. A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy.
Phuengkham H; Song C; Lim YT
Adv Mater; 2019 Oct; 31(42):e1903242. PubMed ID: 31490604
[TBL] [Abstract][Full Text] [Related]
54. Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine.
Zhang H; Chen K; Guo K; Tao J; Song L; Ren S; Zhao Y; Teng Z; Qiu W; Wang Z
Adv Healthc Mater; 2024 Jan; 13(2):e2302195. PubMed ID: 37792547
[TBL] [Abstract][Full Text] [Related]
55. Indocyanine green-loaded polydopamine-iron ions coordination nanoparticles for photoacoustic/magnetic resonance dual-modal imaging-guided cancer photothermal therapy.
Hu D; Liu C; Song L; Cui H; Gao G; Liu P; Sheng Z; Cai L
Nanoscale; 2016 Oct; 8(39):17150-17158. PubMed ID: 27539790
[TBL] [Abstract][Full Text] [Related]
56. Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study.
Thauvin C; Widmer J; Mottas I; Hocevar S; Allémann E; Bourquin C; Delie F
Eur J Pharm Biopharm; 2019 Jun; 139():253-261. PubMed ID: 30981947
[TBL] [Abstract][Full Text] [Related]
57. Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer.
Huang Y; Guan Z; Dai X; Shen Y; Wei Q; Ren L; Jiang J; Xiao Z; Jiang Y; Liu D; Huang Z; Xu X; Luo Y; Zhao C
Nat Commun; 2021 Jul; 12(1):4310. PubMed ID: 34262026
[TBL] [Abstract][Full Text] [Related]
58. Magainin-modified polydopamine nanoparticles for photothermal killing of bacteria at low temperature.
Fan XL; Li HY; Ye WY; Zhao MQ; Huang DN; Fang Y; Zhou BQ; Ren KF; Ji J; Fu GS
Colloids Surf B Biointerfaces; 2019 Nov; 183():110423. PubMed ID: 31437608
[TBL] [Abstract][Full Text] [Related]
59. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation.
Liang X; Ye X; Wang C; Xing C; Miao Q; Xie Z; Chen X; Zhang X; Zhang H; Mei L
J Control Release; 2019 Feb; 296():150-161. PubMed ID: 30682441
[TBL] [Abstract][Full Text] [Related]
60. Polymeric PD-L1 blockade nanoparticles for cancer photothermal-immunotherapy.
Yu Y; Li J; Song B; Ma Z; Zhang Y; Sun H; Wei X; Bai Y; Lu X; Zhang P; Zhang X
Biomaterials; 2022 Jan; 280():121312. PubMed ID: 34896861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
